Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Rejuvenating self-repair mechanisms could improve organ recovery in regenerative medicine.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Timely diagnosis and aggressive treatment with high-dose steroids and B-cell depletion therapies are effective for severe acute cutaneous lupus.

Switching immunosuppressants can improve hair regrowth and well-being in transplant patients experiencing hair loss.

Switching immunosuppressive drugs can improve hair regrowth and well-being in transplant patients with hair loss.

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

Skin disorders in HIV patients have shifted, with more sexually transmitted infections and ART-related conditions now common.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

Transplant patients often get skin problems, with treatments varying by condition.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Trichoscopy can reveal specific hair and scalp changes in linear morphea.

Discoid lupus erythematosus can be mistaken for a skin infection, complicating diagnosis and treatment.

Uveodermatological syndrome in dogs is hard to manage and can lead to blindness despite treatment.

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.